Objective:

To share real-world experiences and workflow strategies from early users of Alcon’s Voyager Direct Selective Laser Trabeculoplasty (DSLT) platform, focusing on specific patient cases and procedural insights.

Approach:

Key Findings:

• DSLT offers fully automated, 360° treatment without the need for a gonioscopy lens.
• The device broadens the range of patients suitable for treatment compared to manual SLT.
• Adjustments in anesthesia techniques are necessary due to higher energy levels used in DSLT.
• Bilateral treatment is preferred to reduce patients' drop burden and improve efficiency.

Interpretation:

The Voyager DSLT enhances the accessibility and effectiveness of glaucoma treatment, with specific adjustments in technique noted to improve patient comfort and procedural efficiency.

Limitations:

• The study is based on experiences from a limited number of early adopters, which may not represent broader clinical practice.
• Real-world outcomes may vary based on individual practice settings and patient populations, potentially affecting the applicability of findings.

Conclusion:

The Voyager DSLT represents a significant advancement in glaucoma treatment, with positive feedback from early users regarding its efficiency and patient comfort, particularly in specific patient scenarios.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.